Document is current
Any future updates will be listed below
-
Authors
Nagai, Yosuke
Matoba, Keiichiro
Nishimura, Rimei
-
Funding
Funding for this research was provided by:
JSPS KAKENHI (21K20914)
JSPS KAKENHI (23K07709)
- License Information
-
More Information
Article History
Received: 11 March 2026
Accepted: 18 June 2026
First Online: 1 July 2026
Declarations
:
: RN has received lecture fees from Sanofi, Medtronic Japan, Nippon Boehringer Ingelheim, Teijin Pharma, Kissei Pharmaceutical, Eli Lilly Japan, Novo Nordisk Pharma, Astellas Pharma, Abbott, Sumitomo Pharma, AstraZeneca, Kowa, and Ono Pharmaceutical. RN has also received research funding (commissioned and collaborative research) from Mitsubishi Electric, Kowa, and Sanofi. KM and YN have no competing interests to declare.
